pegfilgrastim

Open Access
Risk Factors and Clinical Significance of Grade ≥3 Neutropenia During the First Cycle of Cabazitaxel Therapy With Primary Pegfilgrastim Prophylaxis in Metastatic Castration-resistant Prostate Cancer
RYO SATO, YUKIHIRO YOSHIMI, TETSUHARU NISHIO, YU MATSUNAGA and RIKIYA MATSUMOTO

In Vivo May 2026, 40 (3) 1628-1636; DOI: https://doi.org/10.21873/invivo.14313
You have access
Pegfilgrastim Maintains Relative Dose Intensity and Decreases Hospitalisations in Patients With Endometrial Cancer
KENRO CHIKAZAWA, KEN IMAI, TAKAKI ITO, AZUSA KIMURA, KO HIROYOSHI, YOKOTA MIHO, TOMOYUKI KUWATA and RYO KONNO

In Vivo November 2020, 34 (6) 3669-3673; DOI: https://doi.org/10.21873/invivo.12214
You have access
Effectiveness and Safety of Pegfilgrastim in BEP Treatment for Patients with Germ Cell Tumor
HIROAKI IWAMOTO, KOUJI IZUMI, ARIUNBOLD NATSAGDORJ, TOMOYUKI MAKINO, TAKAHIRO NOHARA, KAZUYOSHI SHIGEHARA, YOSHIFUMI KADONO and ATSUSHI MIZOKAMI

In Vivo July 2018, 32 (4) 899-903; DOI: https://doi.org/10.21873/invivo.11326

Main menu